Navigation Links
Celebrex Appears Easier on Stomach for Arthritis Patients
Date:6/17/2010

Diclofenac plus proton pump inhibitor quadrupled risk of gastrointestinal damage, study found

THURSDAY, June 17 (HealthDay News) -- Patients who take the painkiller celecoxib for arthritis pain and inflammation are less likely to suffer gastrointestinal damage than those who take diclofenac plus omeprazole, a new study finds.

Celecoxib (Celebrex) is a cox-2 selective non-steroidal anti-inflammatory drug (NSAID), diclofenac (Voltaren) is a non-selective NSAID and omeprazole (Prilosec) is a proton pump inhibitor (PPI).

The study included 4,484 patients in 32 countries or territories who were randomly selected to receive either 200 milligrams (mg) of celecoxib twice a day (2,238 patients) or 75 mg of diclofenac slow-release plus 20 mg of omeprazole (2,246 patients) once a day.

Patients taking diclofenac plus omeprazole were more than four times more likely to suffer upper or lower gastrointestinal damage than celecoxib patients -- 3.8 percent versus 0.9 percent, respectively.

The findings, which were released online June 17 in advance of publication in a future print issue of The Lancet, should prompt a review of approaches used to reduce the risk of NSAID treatment, said the authors of the CONDOR study.

"Since guidelines recommend that selection of NSAID therapy be driven by consideration of both cardiovascular and gastrointestinal effects of treatment, CONDOR has provided new data relevant to patients requiring anti-inflammatory therapy who are at increased gastrointestinal but not increased cardiovascular risk. In this population, the gastrointestinal outcomes of a cox-2 selective NSAID were quite different to those of a non-selective NSAID plus a PPI," Francis Chan of Prince of Wales Hospital, Hong Kong Special Administrative Region, China, and Jay Goldstein of the University of Illinois at Chicago, and colleagues wrote.

"Further understanding of the cardiovascular outcomes of these two strategies requires the results of ongoing trials that have been designed directly to address that important clinical question. The findings of the CONDOR trial should encourage guideline committees to review their treatment recommendations for arthritis patients," the researchers concluded.

More information

The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more about arthritis.



-- Robert Preidt



SOURCE: The Lancet, news release, June 17, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Can Celebrex prevent cancer-causing colon polyps?
2. Celebrex Might Thwart Inherited Skin Cancers
3. NAMI Medical Director Honored with APA Patient Advocacy Award; Appears in CNN Health and Huffington Post Columns
4. Taking Flu Drugs While Pregnant Appears to Be Safe: Study
5. Hospitalization Appears to Help Personality Disorder Patients
6. How health care is paid for appears to impact outcome
7. Protein Appears Key to Intestinal Balance
8. Medication appears well-tolerated, beneficial in Huntingtons disease patients
9. Ashworth College Instructor Dr. Nicole Detling Miller Appears on Colbert Report
10. Brain Damage: NFL ‘Gets It,' American Society of Anesthesiologists Still Appears ‘Asleep'
11. Traumatic brain injuries: Motor deficits can persist even after what appears to be a full recovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Celebrex Appears Easier on Stomach for Arthritis Patients
(Date:1/7/2020)... ... January 07, 2020 , ... CBD For The People ... keeping the focus on the individual customer service experience. Transparency and integrity are the ... the profits second. By taking care of the people first, they know that satisfied ...
(Date:1/7/2020)... ... ... Iconic singer, choreographer and actress Paula Abdul isn’t just known for ... all time, but also for looking absolutely flawless in her 50s. At 57 years ... to making it through 10 hour rehearsals and aging gracefully. While stretching, pilates, eating ...
(Date:1/7/2020)... ... January 06, 2020 , ... MemoryCare.com ... has announced the Best Memory Care Facilities in Lakeland, Florida. The guide identifies ... amenities. , According to the Alzheimer’s Association , 5.6 million people ...
(Date:1/7/2020)... ... January 07, 2020 , ... R3 Stem ... includes comprehensive presentations and procedures for hair restoration, facial rejuvenation and sexual wellness. ... , Regenerative aesthetics has become incredibly popular over the past few years as ...
(Date:1/7/2020)... ... January 07, 2020 , ... MMJ International Holdings, the ... for ?Orphan Drug Designation? for its THC and CBD proprietary drug formulation which will ... MMJ’s lead drugs and the company is confident that it will bring much needed ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... January 11, 2020 , ... New Life Hiking Spa offers ... information on how to book an affordable option. , Improved health and happiness: ... pace of everyday life, sight see and a try a new cuisine, the joy ...
(Date:1/10/2020)... ... January 10, 2020 , ... Allegheny Health ... that officially brings GCMC into the family of hospitals affiliated with and operated ... network and its patients with a vital new access point for high-quality acute ...
(Date:1/10/2020)... ... January 10, 2020 , ... Myant Inc ... Las Vegas and showcasing a system of connected performance apparel (including a ... their bodies, their training partners and coaches. Connected fitness represents just one facet ...
Breaking Medicine Technology: